Literature DB >> 11410276

Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1.

H R Lijnen1, B Van Hoef, D Collen.   

Abstract

Matrix metalloproteinase-3 (MMP-3 or stromelysin-1) hydrolyzes the Met(374)-Ser(375) (P3-P2), Glu(416)-Leu(417) and Ser(432)-Leu(433) peptide bonds in human alpha(2)-antiplasmin (alpha(2)-AP), the main physiological plasmin inhibitor. Cleavage is completely abolished in the presence of the MMP inhibitors EDTA or 1,10-phenanthroline. At enzyme/substrate ratio of 1:10 at 37 degrees C, alpha(2)-AP protein cleavage occurs with a half-life of 8 min, and is associated with rapid loss of inhibitory activity towards plasmin with a half-life of 5 min. alpha(2)-AP cleaved by MMP-3 does no longer form a stable complex with plasmin, as shown by SDS-PAGE, and does no longer interact with plasminogen, as shown by crossed immunoelectrophoresis with plasminogen added to the gel. These data are compatible with the removal of a COOH-terminal fragment containing the reactive site peptide bond and the plasmin(ogen)-binding site. In addition, MMP-3 cleaves the Pro(19)-Leu(20) peptide bond in alpha(2)-AP, thereby removing the fibrin-binding site from the inhibitor. A dysfunctional alpha(2)-AP variant (Ala-alpha(2)-AP or alpha(2)-AP Enschede), with an alanine insertion in the reactive site sequence converting it from a plasmin inhibitor into a substrate, was also efficiently cleaved by MMP-3 (half-life of 13 min at 37 degrees C and enzyme/substrate ratio of 1:10). Cleavage and inactivation of alpha(2)-AP by MMP-3 may constitute a mechanism favoring local plasmin-mediated proteolysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410276     DOI: 10.1016/s0167-4838(01)00186-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  New functions of the fibrinolytic system in bone marrow cell-derived angiogenesis.

Authors:  Beate Heissig; Makiko Ohki-Koizumi; Yoshihiko Tashiro; Ismael Gritli; Kaori Sato-Kusubata; Koichi Hattori
Journal:  Int J Hematol       Date:  2012-02-07       Impact factor: 2.490

Review 2.  Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.

Authors:  Beate Heissig; Douaa Dhahri; Salita Eiamboonsert; Yousef Salama; Hiroshi Shimazu; Shinya Munakata; Koichi Hattori
Journal:  Cell Mol Life Sci       Date:  2015-09-09       Impact factor: 9.261

Review 3.  Matrix metalloproteinases: regulators of the tumor microenvironment.

Authors:  Kai Kessenbrock; Vicki Plaks; Zena Werb
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 4.  Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics.

Authors:  David J Wilkinson; Maria Del Carmen Arques; Carmen Huesa; Andrew D Rowan
Journal:  Br J Pharmacol       Date:  2018-03-30       Impact factor: 8.739

Review 5.  Serpins in cartilage and osteoarthritis: what do we know?

Authors:  David J Wilkinson
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

6.  Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.

Authors:  André Weiss; Hanna Joerss; Jens Brockmeyer
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

7.  Moonlighting matrix metalloproteinase substrates: Enhancement of proinflammatory functions of extracellular tyrosyl-tRNA synthetase upon cleavage.

Authors:  Parker G Jobin; Nestor Solis; Yoan Machado; Peter A Bell; Simran K Rai; Nam Hoon Kwon; Sunghoon Kim; Christopher M Overall; Georgina S Butler
Journal:  J Biol Chem       Date:  2019-11-26       Impact factor: 5.157

Review 8.  α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis.

Authors:  Yosuke Kanno; En Shu
Journal:  Life (Basel)       Date:  2022-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.